[1]
Tacchetti, C. et al. 2015. A comprehensive analysis of Trastuzumab-induced signaling suggests the role of HER2 in several cell processes and highlights alternative targets for HER2- positive breast cancer therapy. Italian Journal of Anatomy and Embryology. 120, 1 (Sep. 2015), 71.